Eisai Research Institute of Boston, Inc., a pharmaceutical R&D subsidiary of Tokyo-based Eisai Co., Ltd., has opened a new facility at its site in Andover, MA. The 150,000-sq.-ft. structure will consolidate basic discovery research operations and provide for future growth. The $65 million facility will be devoted to discovery research using natural products-based synthetic organic chemistry and target-oriented biology to identify and develop drug compounds. Part of Eisai’s busines...